Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Net Income 2017–2025
Inmune Bio Inc. annual/quarterly net income history and growth rate from 2017 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Inmune Bio Inc. net income for the quarter ending March 31, 2025 was -9.7 M, a 11.66% decrease year-over-year.
- Inmune Bio Inc. net income for the twelve months ending March 31, 2025 was -35.8 M, a 27.95% increase year-over-year.
- Inmune Bio Inc. annual net income for 2025 was -45.9 M, a 9.15% increase from 2024.
- Inmune Bio Inc. annual net income for 2024 was -42.1 M, a 40.24% increase from 2023.
- Inmune Bio Inc. annual net income for 2023 was -30.0 M, a 9.92% increase from 2022.
- Inmune Bio Inc. annual net income for 2022 was -27.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inmune Bio Inc. Net Income — FAQ
Inmune Bio Inc. (INMB) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Inmune Bio Inc.'s net income?
Inmune Bio Inc. (INMB) reported net income of -$46M for fiscal 2025.
Where can I see INMB's net income history?
The chart and table above show Inmune Bio Inc.'s net income by year and by quarter, including the growth rate.